Drug recall · February 22, 2017
Mimvey Lo recall
Why: Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.
- Lots / codes
Lot # 33809881A, Exp 05/17; 33811151A, Exp 08/17
- Quantity
- 17,473 cartons
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide in the United States
- Initiated
- February 2, 2017 · Voluntary: Firm initiated
- Classified
- February 16, 2017
- Reported
- February 22, 2017
- Ended
- February 6, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.